{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T21:31:34Z","timestamp":1792359094506,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":156,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.idcr.2025.e02280","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T19:19:51Z","timestamp":1749237591000},"page":"e02280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["An atypical presentation of immune reconstitution inflammatory syndrome (IRIS) in a patient with cryptococcal meningitis in the setting of fingolimod therapy for multiple sclerosis"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6707-5371","authenticated-orcid":false,"given":"Henco","family":"Nel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siong","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2025.e02280_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(23)00731-4","article-title":"Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM","author":"Chang","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.idcr.2025.e02280_bib2","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/cid\/ciad321","article-title":"Current epidemiology and clinical features of cryptococcus infection in patients without human immunodeficiency virus: a multicenter study in 46 hospitals in Australia and New Zealand","volume":"77","author":"Coussement","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2025.e02280_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101923","article-title":"Cryptococcus neoformans var grubii meningoencephalitis in a patient on fingolimod for relapsing-remitting multiple sclerosis: case report and review of published cases","volume":"39","author":"Ma","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"10.1016\/j.idcr.2025.e02280_bib4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1473-3099(07)70085-3","article-title":"Immune reconstitution syndrome associated with opportunistic mycoses","volume":"7","author":"Singh","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02280_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/cid\/ciu711","article-title":"Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression","volume":"60","author":"Sun","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1-2","key":"10.1016\/j.idcr.2025.e02280_bib6","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0041-1345(98)01975-7","article-title":"FTY720, a novel immunosuppressant, induces sequestration of circulating lymphocytes by acceleration of lymphocyte homing","volume":"31","author":"Chiba","year":"1999","journal-title":"Transpl Proc"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02280_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/cen3.12397","article-title":"Neurological safety of fingolimod: an updated review","volume":"8","author":"Yoshii","year":"2017","journal-title":"Clin Exp Neuroimmunol"},{"issue":"10","key":"10.1016\/j.idcr.2025.e02280_bib8","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/jamaneurol.2015.1746","article-title":"Cryptococcal meningoencephalitis in a patient with multiple sclerosis treated with fingolimod","volume":"72","author":"Achtnichts","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.idcr.2025.e02280_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clinimag.2018.11.005","article-title":"Cryptococcal meningitis in a multiple sclerosis patient treated with fingolimod: a case report and review of imaging findings","volume":"54","author":"Chong","year":"2019","journal-title":"Clin Imaging"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02280_bib10","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001156","article-title":"Cryptococcal meningitis reported with fingolimod treatment: case series","volume":"9","author":"Del Poeta","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.idcr.2025.e02280_bib11","unstructured":"Fingolimod prescribing information. [Available from: \u3008\u3008http:\/\/www.pharma.us.novartis.com\/product\/pi\/pdf\/gilenya.pdf\u3009\u3009."},{"key":"10.1016\/j.idcr.2025.e02280_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.msard.2016.06.007","article-title":"Cryptococcal meningitis after fingolimod discontinuation in a patient with multiple sclerosis","volume":"9","author":"Ward","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.idcr.2025.e02280_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-220026","article-title":"Cryptococcal meningitis causing obstructive hydrocephalus in a patient on fingolimod","volume":"2017","author":"Pham","year":"2017","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.idcr.2025.e02280_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103072","article-title":"Fingolimod-related cryptococcal meningoencephalitis and immune reconstitution inflammatory syndrome in a patient with multiple sclerosis","volume":"53","author":"Cuascut","year":"2021","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02280_bib15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1574-6976.2011.00286.x","article-title":"Profiling a killer, the development of cryptococcus neoformans","volume":"36","author":"Kozubowski","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.idcr.2025.e02280_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-micro-020518-120210","article-title":"Life cycle of cryptococcus neoformans","volume":"73","author":"Zhao","year":"2019","journal-title":"Annu Rev Microbiol"},{"issue":"26","key":"10.1016\/j.idcr.2025.e02280_bib17","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMc1305981","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Day","year":"2013","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.idcr.2025.e02280_bib18","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1312884","article-title":"Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis","volume":"370","author":"Boulware","year":"2014","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.idcr.2025.e02280_bib19","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMra2311057","article-title":"Cryptococcal disease in diverse hosts","volume":"390","author":"Meya","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idcr.2025.e02280_bib20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.msard.2016.07.015","article-title":"Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: a case report and review of literature","volume":"9","author":"Grebenciucova","year":"2016","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02280_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1056\/NEJMoa0907839","article-title":"Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis","volume":"362","author":"Cohen","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02280_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","article-title":"Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis","volume":"33","author":"Chun","year":"2010","journal-title":"Clin Neuropharmacol"},{"issue":"14","key":"10.1016\/j.idcr.2025.e02280_bib23","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1212\/WNL.0b013e3182143564","article-title":"Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS","volume":"76","author":"Kowarik","year":"2011","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.idcr.2025.e02280_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/1352458513500551","article-title":"Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy","volume":"20","author":"Francis","year":"2014","journal-title":"Mult Scler"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02280_bib25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02280_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw038","article-title":"Acute cryptococcal immune reconstitution inflammatory syndrome in a patient on natalizumab","volume":"3","author":"Gundacker","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"1-2","key":"10.1016\/j.idcr.2025.e02280_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jns.2014.03.007","article-title":"Cryptococcal meningitis in a multiple sclerosis patient taking natalizumab","volume":"340","author":"Valenzuela","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.idcr.2025.e02280_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102137","article-title":"Cryptococcal meningitis in a patient with multiple sclerosis on dimethyl fumarate treatment: a case report","volume":"42","author":"Workel","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02280_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jamaneurol.2014.3065","article-title":"Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management","volume":"72","author":"Arvin","year":"2015","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02280_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s40263-015-0226-2","article-title":"Infection risk in patients on multiple sclerosis therapeutics","volume":"29","author":"Williamson","year":"2015","journal-title":"CNS Drugs"},{"issue":"16","key":"10.1016\/j.idcr.2025.e02280_bib31","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/01.wnl.0000327609.57688.ea","article-title":"FTY720 therapy exerts differential effects on t cell subsets in multiple sclerosis","volume":"71","author":"Mehling","year":"2008","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.idcr.2025.e02280_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae316","article-title":"Cryptococcosis associated with biologic therapy: a narrative review","volume":"11","author":"Li","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02280_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02280_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004884","article-title":"Paradoxical immune responses in Non-HIV cryptococcal meningitis","volume":"11","author":"Panackal","year":"2015","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02280_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12281-019-00345-7","article-title":"Clinical aspects of immune damage in cryptococcosis","volume":"13","author":"Anjum","year":"2019","journal-title":"Curr Fungal Infect Rep"},{"issue":"9","key":"10.1016\/j.idcr.2025.e02280_bib36","doi-asserted-by":"crossref","first-page":"e2789","DOI":"10.1093\/cid\/ciaa1901","article-title":"Outcomes in previously healthy cryptococcal meningoencephalitis patients treated with pulse taper corticosteroids for Post-infectious inflammatory syndrome","volume":"73","author":"Anjum","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02280_bib37","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/TP.0b013e3181814e76","article-title":"Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings","volume":"86","author":"Singh","year":"2008","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02280_bib38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/jon.12291","article-title":"Diagnostic performance of brain MRI in immune reconstitution inflammatory syndrome","volume":"26","author":"Narvid","year":"2016","journal-title":"J Neuroimaging"},{"issue":"4","key":"10.1016\/j.idcr.2025.e02280_bib39","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/cid\/ciy567","article-title":"Impact of routine cryptococcal antigen screening and targeted preemptive fluconazole therapy in Antiretroviral-naive human immunodeficiency Virus-infected adults with CD4 cell counts <100\/\u03bcL: a systematic review and Meta-analysis","volume":"68","author":"Temfack","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idcr.2025.e02280_bib40","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1128\/CVI.00242-07","article-title":"Serologic evidence for reactivation of cryptococcosis in solid-organ transplant recipients","volume":"14","author":"Saha","year":"2007","journal-title":"Clin Vaccin Immunol"},{"issue":"9","key":"10.1016\/j.idcr.2025.e02280_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13543","article-title":"Cryptococcosis in solid organ transplantation-Guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Baddley","year":"2019","journal-title":"Clin Transpl"},{"issue":"4","key":"10.1016\/j.idcr.2025.e02280_bib42","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1212\/CPJ.0000000000001051","article-title":"Cryptococcal meningitis in a Fingolimod-Treated patient: positive antigen test a year before onset","volume":"11","author":"Aoki","year":"2021","journal-title":"Neurol Clin Pract"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250925001362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250925001362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T22:59:35Z","timestamp":1762383575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250925001362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":42,"alternative-id":["S2214250925001362"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02280","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An atypical presentation of immune reconstitution inflammatory syndrome (IRIS) in a patient with cryptococcal meningitis in the setting of fingolimod therapy for multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02280"}}